LIGAND PHARMACEUTICALS INCORPORATED Finite-Lived Intangible Assets, Accumulated Amortization
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Finite-Lived Intangible Assets, Accumulated Amortization of $11.60 million as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2023-02-28
- 2022-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $11.60M.
- 2021-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $11.70M.
- 2013-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $6.37M.
- 2013-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $5.78M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization |
|---|---|
| 2022-12-31 | $11.60M 10-K · filed 2023-02-28 |
| 2021-12-31 | $11.70M 10-K · filed 2023-02-28 |
| 2013-09-30 | $6.37M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $5.78M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $5.19M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $4.59M 10-Q · filed 2013-11-08 |
| 2012-09-30 | $3.92M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $3.34M 10-Q/A · filed 2012-11-14 |
| 2011-12-31 | $2.18M 10-K · filed 2013-03-14 |